BrightSpring Health Services (NASDAQ:BTSG) Announces Earnings Results

BrightSpring Health Services (NASDAQ:BTSG) released its earnings results on Friday. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07, FiscalAI reports. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. The firm had revenue of $4.21 billion for the quarter, compared to analyst estimates of $3.88 billion. The firm’s quarterly revenue was up 26.4% on a year-over-year basis.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Strong third-quarter performance: Revenue rose 26% year over year to $4.2 billion, adjusted EBITDA increased 42% to $228 million, and adjusted EPS grew 80% to $0.54. Results exceeded the company’s forecast, supported by broad-based growth across Pharmacy Solutions and Provider Services.
• Specialty and infusion pharmacy revenue grew 34%, driven by 29% script growth, strong branded limited-distribution drug launches, generic contributions, pharma services, and mid-teens growth in acute and chronic infusion. BrightSpring launched seven additional LDDs during the quarter and now supports 162 total therapies.
• Provider Services revenue increased 31%, with home health census up approximately 58% and continued momentum in rehab and personal care. Management expects the acquired Amedisys and LHC branches to contribute approximately $35 million of adjusted EBITDA in 2026.
• BrightSpring raised or reaffirmed a strong outlook, projecting 2026 adjusted EBITDA of $850 million-$860 million and more than $700 million of operating cash flow, while reiterating expectations for at least 15%-20% organic adjusted EBITDA growth in 2027. Leverage declined to 1.79 times, including the impact of $120 million in year-to-date share repurchases.
• Home and community pharmacy revenue declined 6% year over year, primarily because of approximately $50 million of quarterly impact from the Inflation Reduction Act and exits from uneconomic customers. Management expects the IRA to remain a roughly $50 million headwind in the fourth quarter, although underlying growth and profitability are improving.

BrightSpring Health Services Stock Up 10.6%

Shares of BTSG traded up $6.40 during trading hours on Friday, reaching $66.62. 4,454,927 shares of the stock traded hands, compared to its average volume of 2,847,854. BrightSpring Health Services has a 52 week low of $30.64 and a 52 week high of $73.75. The company has a market cap of $13.18 billion, a price-to-earnings ratio of 40.13, a PEG ratio of 0.77 and a beta of 1.87. The stock has a fifty day simple moving average of $59.79 and a 200 day simple moving average of $54.40. The company has a current ratio of 1.59, a quick ratio of 1.22 and a debt-to-equity ratio of 1.06.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Wells Fargo & Company increased their target price on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. BMO Capital Markets reiterated an “outperform” rating on shares of BrightSpring Health Services in a report on Friday, October 2nd. Guggenheim initiated coverage on BrightSpring Health Services in a research note on Monday, July 13th. They set a “buy” rating and a $81.00 price target on the stock. BTIG Research reissued a “buy” rating and issued a $90.00 price objective on shares of BrightSpring Health Services in a research note on Thursday, August 13th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of BrightSpring Health Services in a report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, BrightSpring Health Services presently has an average rating of “Moderate Buy” and a consensus price target of $72.88.

BrightSpring Health Services News Roundup

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Third-quarter earnings exceeded expectations. BrightSpring reported adjusted earnings of $0.54 per share, up from $0.30 a year earlier and above analyst estimates ranging from $0.47 to $0.49. This marked another quarterly earnings beat for the company. BrightSpring Q3 earnings and revenue results
• Positive Sentiment: Revenue growth was substantially stronger than forecast. Quarterly revenue rose 26.4% year over year to $4.21 billion, surpassing the $3.88 billion consensus estimate. The revenue performance indicates continued expansion across BrightSpring’s healthcare services platform. BrightSpring Q3 revenue report
• Positive Sentiment: Management increased full-year 2026 guidance. BrightSpring raised its revenue and adjusted EBITDA outlook, reinforcing investor confidence that operating momentum and profitability will remain strong. BrightSpring reports Q3 results and raises guidance
• Positive Sentiment: Profitability improved. BrightSpring posted a 16.73% return on equity and a 2.55% net margin, while the earnings beat and stronger revenue helped support the positive market reaction. BrightSpring bottom-line results

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.